RAPT Therapeutics Statistics

Total Valuation

RAPT has a market cap or net worth of $97.38 million. The enterprise value is -$37.88 million.

Market Cap	97.38M
Enterprise Value	-37.88M

Important Dates

The next estimated earnings date is Friday, August 9, 2024, before market open.

Earnings Date	Aug 9, 2024
Ex-Dividend Date	n/a

Share Statistics

RAPT has 34.90 million shares outstanding. The number of shares has increased by 0.90% in one year.

Shares Outstanding	34.90M
Shares Change (YoY)	+0.90%
Shares Change (QoQ)	+0.63%
Owned by Insiders (%)	1.85%
Owned by Institutions (%)	94.11%
Float	31.55M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.74
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.01, with a Debt / Equity ratio of 0.05.

Current Ratio	7.01
Quick Ratio	n/a
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -72.60% and return on invested capital (ROIC) is -93.34%.

Return on Equity (ROE)	-72.60%
Return on Assets (ROA)	-63.00%
Return on Capital (ROIC)	-93.34%
Revenue Per Employee	n/a
Profits Per Employee	-$936,889
Employee Count	126
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -85.29% in the last 52 weeks. The beta is 0.40, so RAPT's price volatility has been lower than the market average.

Beta (5Y)	0.40
52-Week Price Change	-85.29%
50-Day Moving Average	4.87
200-Day Moving Average	13.00
Relative Strength Index (RSI)	25.32
Average Volume (20 Days)	480,296

Short Selling Information

The latest short interest is 2.85 million, so 8.15% of the outstanding shares have been sold short.

Short Interest	2.85M
Short Previous Month	2.66M
Short % of Shares Out	8.15%
Short % of Float	9.02%
Short Ratio (days to cover)	4.27

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-128.02M
Pretax Income	-118.05M
Net Income	-118.05M
EBITDA	-114.48M
EBIT	-118.05M
Earnings Per Share (EPS)	-$3.08

Full Income Statement

Balance Sheet

The company has $141.58 million in cash and $6.32 million in debt, giving a net cash position of $135.26 million or $3.88 per share.

Cash & Cash Equivalents	141.58M
Total Debt	6.32M
Net Cash	135.26M
Net Cash Per Share	$3.88
Equity (Book Value)	130.84M
Book Value Per Share	3.75
Working Capital	127.19M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$105.53 million and capital expenditures -$471,000, giving a free cash flow of -$106.00 million.

Operating Cash Flow	-105.53M
Capital Expenditures	-471,000
Free Cash Flow	-106.00M
FCF Per Share	-$2.74

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

RAPT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.90%
Shareholder Yield	-0.90%
Earnings Yield	-121.22%
FCF Yield	-108.85%

Analyst Forecast

The average price target for RAPT is $18.00, which is 545.16% higher than the current price. The consensus rating is "Hold".

Price Target	$18.00
Price Target Difference	545.16%
Analyst Consensus	Hold
Analyst Count	11
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-6.34%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2